A 52‐week update of a multicentre real‐life experience on effectiveness and safety of risankizumab in psoriasis
Katharina Hansel, Arianna Zangrilli, Luca Bianchi, Ketty Peris, Andrea Chiricozzi, Annamaria Offidani, Federico Diotallevi, Maria Concetta Fargnoli, Maria Esposito, Paolo Amerio, Giulio Gualdi, Luca Bianchi, Luca Stingeni
Abstract
Data available on request from the authors.
Topics & Concepts
MedicinePsoriasisDermatologyPsoriasis: Treatment and PathogenesisDermatology and Skin DiseasesAsthma and respiratory diseases